Cargando…

Altered expression of the suppressors PML and p53 in glioblastoma cells with the antisense-EGF-receptor

Gene amplification and enhanced expression of the epidermal growth factor receptor (EGFR) represent the major molecular genetic alteration in glioblastomas and it may play an essential role in cell growth and in the carcinogenic process. On the other hand, the nuclear suppressor proteins PML and p53...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tian, X X, Chan, J Y H, Pang, J C S, Chen, J, He, J H, To, T S S, Leung, S F, Ng, H K
Formato:	Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 1999
Materias:	Regular Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2362944/ https://www.ncbi.nlm.nih.gov/pubmed/10576656 http://dx.doi.org/10.1038/sj.bjc.6690798

Ejemplares similares

Antisense epidermal growth factor receptor RNA transfection in human glioblastoma cells down-regulates telomerase activity and telomere length
por: Tian, X-X, et al.
Publicado: (2002)

p53 protein, EGF receptor, and anti-p53 antibodies in serum from patients with occupationally derived lung cancer
por: Schneider, J, et al.
Publicado: (1999)

Regulating the p53 Tumor Suppressor Network at PML Biomolecular Condensates
por: Liebl, Magdalena C., et al.
Publicado: (2022)

Is PML a Tumor Suppressor?
por: Mazza, Massimiliano, et al.
Publicado: (2013)

Activation and activities of the p53 tumour suppressor protein
por: Bálint, É, et al.
Publicado: (2001)

Complex post-transcriptional regulation of EGF-receptor expression by EGF and TGF-α in human prostate cancer cells
por: Seth, D, et al.
Publicado: (1999)

Tumor Suppressor WWOX and p53 Alterations and Drug Resistance in Glioblastomas
por: Chiang, Ming-Fu, et al.
Publicado: (2013)

PML Surfs into HIPPO Tumor Suppressor Pathway
por: Strano, Sabrina, et al.
Publicado: (2013)

Deacetylation of the tumor suppressor protein PML regulates hydrogen peroxide-induced cell death
por: Guan, D, et al.
Publicado: (2014)

Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations
por: Rashid, A, et al.
Publicado: (1999)

BMK1 is involved in the regulation of p53 through disrupting the PML-MDM2 interaction
por: Yang, Q, et al.
Publicado: (2012)

Evidence for the differential expression of a variant EGF receptor protein in human prostate cancer
por: Olapade-Olaopa, E O, et al.
Publicado: (2000)

Expression of the novel tumour suppressor p33(ING1) is independent of p53
por: Cheung, K-J J, et al.
Publicado: (2000)

Bcl-2 expression related to altered p53 protein and its impact on the progression of human pancreatic carcinoma
por: Hu, Y-X, et al.
Publicado: (1999)

Amphiregulin acts as an autocrine growth factor in two human polarizing colon cancer lines that exhibit domain selective EGF receptor mitogenesis
por: Damstrup, L, et al.
Publicado: (1999)

Expression of p73, a novel protein related to the p53 tumour suppressor p53, and apoptosis in cholangiocellular carcinoma of the liver
por: Tannapfel, A, et al.
Publicado: (1999)

Reduced p21(WAF1/CIP1)protein expression is predominantly related to altered p53 in hepatocellular carcinomas
por: Shi, Y-Z, et al.
Publicado: (2000)

Regulation of NF-κB by PML and PML-RARα
por: Ahmed, Abrar, et al.
Publicado: (2017)

Regulation of the tumor suppressor PML by sequential post-translational modifications
por: Schmitz, M. Lienhard, et al.
Publicado: (2012)

The function, regulation and therapeutic implications of the tumor suppressor protein, PML
por: Guan, Dongyin, et al.
Publicado: (2015)

Pancreatic cancer cells require an EGF receptor-mediated autocrine pathway for proliferation in serum-free conditions
por: Murphy, L O, et al.
Publicado: (2001)

Association between cyclo-oxygenase-2 overexpression and missense p53 mutations in gastric cancer
por: Leung, W K, et al.
Publicado: (2001)

Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts
por: Burt, E C, et al.
Publicado: (2000)

Activity and Cellular Localization of an Oncogenic Glioblastoma Multiforme-associated EGF Receptor Mutant Possessing a Duplicated Kinase Domain
por: Ozer, Byram H., et al.
Publicado: (2009)

Altered expression of the IGF-1 receptor in a tamoxifen-resistant human breast cancer cell line
por: Parisot, J P, et al.
Publicado: (1999)

Transcriptional repression of CDKN2D by PML/RARα contributes to the altered proliferation and differentiation block of acute promyelocytic leukemia cells
por: Wang, Y, et al.
Publicado: (2014)

Novel function of the tumor suppressor PML at ER-mitochondria sites in the control of autophagy
por: Missiroli, Sonia, et al.
Publicado: (2017)

Genetic variations in EGF and EGFR and glioblastoma outcome
por: Sjöström, Sara, et al.
Publicado: (2010)

PRMT5 is required for cell-cycle progression and p53 tumor suppressor function
por: Scoumanne, A., et al.
Publicado: (2009)

Molecular Neuropathology in Practice: Clinical Profiling and Integrative Analysis of Molecular Alterations in Glioblastoma
por: Nasrallah, MacLean P., et al.
Publicado: (2019)

PML and PML-like exonucleases restrict retrotransposons in jawed vertebrates
por: Mathavarajah, Sabateeshan, et al.
Publicado: (2023)

PML Degradation: Multiple Ways to Eliminate PML
por: Rabellino, Andrea, et al.
Publicado: (2013)

A multifactorial approach including tumoural epidermal growth factor receptor, p53, thymidylate synthase and dihydropyrimidine dehydrogenase to predict treatment outcome in head and neck cancer patients receiving 5-fluorouracil
por: Etienne, M C, et al.
Publicado: (1999)

Inhibition of EGF Uptake by Nephrotoxic Antisense Drugs In Vitro and Implications for Preclinical Safety Profiling
por: Moisan, Annie, et al.
Publicado: (2017)

Antisense protein of HTLV-2 (APH-2) associates with PML nuclear bodies: molecular determinants and functional implications
por: Journo, Chloé, et al.
Publicado: (2014)

Connecting signaling and metabolic pathways in EGF receptor-mediated oncogenesis of glioblastoma
por: Bag, Arup K., et al.
Publicado: (2019)

Genetic aberrations in glioblastoma multiforme: translocation of chromosome 10 in an O-2A-like cell line
por: Mao, X, et al.
Publicado: (1999)

Inhibition of breast cancer growth in vivo by antiangiogenesis gene therapy with adenovirus-mediated antisense-VEGF
por: Im, S-A, et al.
Publicado: (2001)

p53 mutations in urinary bladder cancer
por: Berggren, P, et al.
Publicado: (2001)

The p97/VCP segregase is essential for arsenic-induced degradation of PML and PML-RARA
por: Jaffray, Ellis G., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_cnd4r9c70r16ogn2rop95c6ljg